Autonomic Nervous System Drugs Practice Questions

Q: All of the following are substitutes for atropine except?

Drotaverin. **Explanation:** The question asks to identify the drug that is **not** a substitute for atropine. Atropine is a non-selective muscarinic antagonist (anticholinergic). Its substitutes are synthetic or semi-synthetic derivatives designed to have more specific actions or fewer side effects. **Why Drotaverine is the Correct Answer:** Drotaverine is a **phosphodiesterase-4 (PDE4) inhibitor**, not an anticholinergic. It acts as a direct-acting smooth muscle relaxant by increasing intracellular cAMP levels. Unlike atropine substitutes, it does not block muscarinic receptors and therefore does not cause typical anticholinergic side effects like dry mouth or blurred vision. It is primarily used as an antispasmodic for biliary, renal, and gastrointestinal colic. **Analysis of Incorrect Options (Atropine Substitutes):** * **Procyclidine:** An **Antimuscarinic** used in Parkinsonism and drug-induced extrapyramidal symptoms. It crosses the blood-brain barrier to reduce cholinergic overactivity in the basal ganglia. * **Propantheline:** A **Quaternary ammonium compound** used as a gastrointestinal antispasmodic. Due to its polar nature, it has poor CNS penetration and acts primarily on peripheral muscarinic receptors. * **Tiotropium:** A **Long-acting muscarinic antagonist (LAMA)** used via inhalation for COPD and asthma. It provides bronchodilation by blocking M3 receptors in the bronchial smooth muscle. **High-Yield Clinical Pearls for NEET-PG:** * **Mydriatic substitutes:** Cyclopentolate, Tropicamide (shorter duration than atropine). * **Antispasmodic substitutes:** Dicyclomine, Oxybutynin (used for overactive bladder). * **Pre-anesthetic substitute:** Glycopyrrolate (Quaternary ammonium; does not cross BBB, less tachycardia than atropine). * **Ipratropium/Tiotropium** are preferred in COPD because they do not inhibit mucociliary clearance, unlike atropine.

Q: All of the following are peripherally acting muscle relaxants except?

Baclofen. Skeletal muscle relaxants are broadly classified into two categories based on their site of action: **Peripherally acting** (acting at the neuromuscular junction or on the muscle fiber itself) and **Centrally acting** (acting on the spinal cord or brain) [3]. **Why Baclofen is the Correct Answer:** **Baclofen** is a **centrally acting** muscle relaxant [3]. It is a **GABA-B receptor agonist** that works primarily at the spinal cord level [3]. By activating these receptors, it induces hyperpolarization, leading to pre-synaptic inhibition of excitatory neurotransmitters (like glutamate) [3]. It is clinically used to treat spasticity associated with multiple sclerosis or spinal cord injuries [3]. **Analysis of Incorrect Options:** * **Pancuronium:** A peripherally acting **Non-depolarizing Neuromuscular Blocker**. It competes with acetylcholine for nicotinic receptors ($N_m$) at the motor endplate. * **Succinylcholine:** A peripherally acting **Depolarizing Neuromuscular Blocker** [1]. It acts as an agonist at $N_m$ receptors, causing persistent depolarization and subsequent paralysis [1]. * **Dantrolene:** A peripherally acting relaxant that acts directly on the muscle fiber [2]. It inhibits the **Ryanodine receptors (RyR1)** on the sarcoplasmic reticulum, preventing the release of calcium required for contraction [3]. **High-Yield NEET-PG Pearls:** * **Dantrolene** is the drug of choice for **Malignant Hyperthermia** and Neuroleptic Malignant Syndrome. * **Succinylcholine** is known for causing post-operative muscle pain and hyperkalemia (avoid in burn/trauma patients) [1]. * **Tizanidine** is another centrally acting relaxant that acts as an **$\alpha_2$ adrenergic agonist** [3]. * **Mephenesin** is the prototype for centrally acting muscle relaxants [4].

Q: Which of the following drugs exhibits an antispasmodic effect?

Propantheline. ### Explanation **Correct Option: B. Propantheline** Propantheline is a **synthetic quaternary ammonium anticholinergic** drug. It acts as a competitive antagonist at muscarinic receptors ($M_3$ subtype) on smooth muscles. By blocking parasympathetic (cholinergic) stimulation, it reduces the tone and motility of the gastrointestinal, biliary, and urinary tracts. This relaxation of smooth muscle is known as an **antispasmodic effect**. Because it is a quaternary ammonium compound, it has poor CNS penetration and is primarily used for peptic ulcers, gastritis, and irritable bowel syndrome (IBS). **Analysis of Incorrect Options:** * **A. Neostigmine:** This is a reversible **acetylcholinesterase inhibitor**. It increases the concentration of acetylcholine at the neuromuscular junction and muscarinic sites. Instead of being an antispasmodic, it *increases* GI motility and is used to treat paralytic ileus and myasthenia gravis. * **C. Nikethamide:** This is a **CNS and respiratory stimulant** (analeptic). It acts on the brainstem to increase the rate and depth of respiration. It has no significant effect on smooth muscle spasms. * **D. Ambenonium:** Similar to Neostigmine, this is a long-acting **cholinesterase inhibitor** used primarily in the management of myasthenia gravis. It enhances cholinergic activity, which would promote rather than inhibit muscle contraction. **NEET-PG High-Yield Pearls:** * **Quaternary Anticholinergics:** Propantheline, Oxyphenonium, and Clidinium are used as "gastric antispasmodics." * **Dicyclomine:** A tertiary amine anticholinergic often preferred for IBS due to its additional direct smooth muscle relaxant action. * **Hyoscine (Scopolamine) butylbromide:** A potent antispasmodic used for acute biliary or renal colic. * **Key Distinction:** Anticholinergics *decrease* secretions and motility (antispasmodic), while Cholinergics *increase* them (prokinetic).

Q: Which of the following conditions is a contraindication to vasoconstrictors?

All of the above. **Explanation:** Vasoconstrictors, primarily sympathomimetic amines like **Adrenaline (Epinephrine)** and **Noradrenaline**, act on alpha and beta-adrenergic receptors. Their primary effects include peripheral vasoconstriction (increasing blood pressure) and cardiac stimulation (increasing heart rate and oxygen demand). **Why "All of the above" is correct:** The underlying medical concept is the risk of **exacerbating cardiovascular strain** or triggering life-threatening events in patients with pre-existing sympathetic overactivity or cardiac compromise. * **Thyrotoxicosis:** In hyperthyroidism, there is an upregulation of beta-adrenergic receptors. Administering vasoconstrictors can trigger a "thyroid storm," leading to severe tachycardia, arrhythmias, and heart failure. * **Hypertension:** Vasoconstrictors (via $\alpha_1$ receptors) further increase peripheral vascular resistance, which can lead to a hypertensive crisis or cerebrovascular accidents (stroke). * **Myocardial Infarction (MI):** These drugs increase the heart rate and force of contraction (via $\beta_1$ receptors), significantly raising myocardial oxygen demand. In an infarcted heart, this can extend the area of ischemia or trigger fatal ventricular arrhythmias. **Clinical Pearls for NEET-PG:** * **Local Anesthesia (LA):** Vasoconstrictors are often added to LA to prolong duration and reduce toxicity. However, they are strictly contraindicated in **"end-artery" areas** (fingers, toes, nose, earlobes, and penis) due to the risk of gangrene. * **Drug Interaction:** Use caution in patients on **Non-selective Beta-blockers** (e.g., Propranolol); adding Adrenaline can cause an unopposed alpha-effect, leading to severe hypertension and reflex bradycardia. * **Tricyclic Antidepressants (TCAs):** They potentiate the effects of direct-acting vasoconstrictors by inhibiting reuptake.

Q: What is the mechanism of action of Oxybutynin?

Anticholinergic. **Explanation:** **Oxybutynin** is a competitive **muscarinic receptor antagonist** (anticholinergic). Its primary mechanism involves blocking **M3 receptors** on the detrusor muscle of the bladder. By inhibiting the action of acetylcholine, it reduces detrusor contractions, increases bladder capacity, and delays the initial desire to void. * **Why Option B is Correct:** Oxybutynin belongs to the class of tertiary amine anticholinergics. It provides symptomatic relief in overactive bladder (OAB) by exerting both antimuscarinic and direct papaverine-like relaxant effects on smooth muscles. * **Why Option A is Incorrect:** Cholinergic drugs (like Bethanechol) stimulate bladder contraction and are used for urinary retention, the opposite of Oxybutynin’s clinical use. * **Why Option C is Incorrect:** Adrenergic drugs act on alpha or beta receptors. While $\beta_3$ agonists (e.g., Mirabegron) are also used for OAB, Oxybutynin does not act on the adrenergic system. * **Why Option D is Incorrect:** Oxybutynin is a **non-selective** muscarinic antagonist (blocking M1, M2, and M3), though its therapeutic effect in the bladder is mediated via **M3 receptors**. It does not selectively inhibit M2. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Drug of choice for **Overactive Bladder (OAB)** and Urge Incontinence. * **Side Effects:** Typical anticholinergic profile—dry mouth (xerostomia), blurred vision, constipation, and confusion (especially in the elderly due to CNS penetration). * **Alternative:** **Darifenacin and Solifenacin** are preferred by some because they are more **M3-selective**, potentially causing fewer systemic side effects.

Q: Which of the following is NOT true about d-Tubocurarine (d-TC)?

Causes hypotension by ganglion blocking action.. **Explanation:** d-Tubocurarine (d-TC) is the prototype of non-depolarizing (competitive) neuromuscular blockers. Understanding its side-effect profile is crucial for NEET-PG. **Why Option B is the correct answer (The "NOT true" statement):** While d-TC does cause hypotension, the primary mechanism is **histamine release** from mast cells, not significant ganglion blockade. Although d-TC has some weak ganglion-blocking properties, the profound drop in blood pressure and associated bronchospasm are clinically attributed to histamine. In modern practice, newer agents like Vecuronium are preferred because they lack this histamine-releasing property. **Analysis of other options:** * **Option A:** d-TC is highly polar and is primarily excreted **unchanged in the urine** (approx. 70%). This makes it contraindicated in patients with renal failure. * **Option C:** d-TC possesses **vagolytic action** (antimuscarinic effect at the heart), which can contribute to tachycardia, though this effect is more pronounced with Gallamine. * **Option D:** d-TC is a **long-acting** muscle relaxant. Its effects typically last for **2-3 hours**, making it unsuitable for short procedures like intubation. **High-Yield NEET-PG Pearls:** 1. **Hofmann Elimination:** Remember that *Atracurium* and *Cisatracurium* undergo spontaneous degradation (Hofmann elimination) and are the drugs of choice in liver/kidney failure. 2. **Reversal:** The blockade of d-TC is reversed by Acetylcholinesterase inhibitors like **Neostigmine**. 3. **Order of Paralysis:** Small, rapid muscles (eyes, fingers) are paralyzed first; the **diaphragm** is the last to be paralyzed and the first to recover.

Q: What is the site of action of vecuronium?

Myoneural junction. **Explanation:** **Vecuronium** is a non-depolarizing neuromuscular blocking agent (NMBA) belonging to the aminosteroid group. **1. Why the Correct Answer is Right:** The primary site of action for vecuronium is the **myoneural junction** (also known as the neuromuscular junction or NMJ). It acts as a competitive antagonist at the **nicotinic acetylcholine receptors (Nm)** located on the post-junctional motor endplate. By binding to these receptors, vecuronium prevents acetylcholine from triggering depolarization, thereby leading to flaccid skeletal muscle paralysis. **2. Why the Other Options are Incorrect:** * **Cerebrum & Reticular Formation (Options A & B):** Vecuronium is a quaternary ammonium compound, making it highly polar and lipid-insoluble. Consequently, it **cannot cross the blood-brain barrier (BBB)**. It has no effect on the Central Nervous System (CNS), meaning it provides no sedation or analgesia. * **Motor Neuron (Option C):** Vecuronium does not inhibit the electrical conduction along the nerve axon or the release of acetylcholine from the pre-synaptic terminal; its action is strictly post-synaptic at the muscle endplate. **3. Clinical Pearls for NEET-PG:** * **Metabolism:** It is primarily excreted via **bile** (undergoes hepatic metabolism), making it safer than pancuronium in renal failure, though caution is still advised. * **Cardiovascular Stability:** Unlike tubocurarine or pancuronium, vecuronium has minimal histamine release and lacks significant vagolytic effects, ensuring high cardiovascular stability. * **Reversal:** Its effects can be reversed using acetylcholinesterase inhibitors (e.g., **Neostigmine**) or the specific chelating agent **Sugammadex**. * **Intermediate Acting:** It has an intermediate duration of action (approx. 30–40 minutes).

Q: A patient with hypertension also suffers from essential tremor. What is the optimal treatment for this patient?

Propranolol. **Explanation:** The correct answer is **Propranolol**. This is a classic "two birds, one stone" clinical scenario frequently tested in NEET-PG, where a single drug manages two comorbid conditions. **1. Why Propranolol is Correct:** Propranolol is a **non-selective beta-blocker** (blocking both $\beta_1$ and $\beta_2$ receptors). While $\beta_1$ blockade helps manage hypertension by reducing cardiac output and renin release [1], the **$\beta_2$ blockade** is crucial for treating essential tremors [2]. Essential tremors are mediated by peripheral $\beta_2$ receptors in the skeletal muscles; blocking these receptors reduces the amplitude of the tremors [2]. Its high lipid solubility also allows it to cross the blood-brain barrier, potentially contributing to its efficacy. **2. Why Other Options are Incorrect:** * **Clonidine:** An $\alpha_2$ agonist used for hypertension, but it has no effect on skeletal muscle tremors. * **Metoprolol:** A **cardioselective ($\beta_1$) blocker**. While effective for hypertension, it is significantly less effective than propranolol for essential tremors because it lacks potent $\beta_2$ receptor antagonism [2]. * **Lidocaine:** A Class Ib antiarrhythmic and local anesthetic. It has no role in the chronic management of hypertension or essential tremors. **3. Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Propranolol is the DOC for Essential Tremor and Prophylaxis of Migraine [1], [2]. * **Contraindications:** Avoid propranolol in patients with **Asthma or COPD** (due to $\beta_2$ blockade causing bronchoconstriction) and **Diabetes Mellitus** (masks hypoglycemia symptoms). * **Other uses:** It is also used in Performance Anxiety (Stage fright), Hyperthyroidism (to control symptoms and inhibit peripheral T4 to T3 conversion) [2], and Portal Hypertension [1].

Q: What is the most predictive and dangerous side effect of propranolol that makes it to be avoided in a known patient of COPD?

Acute asthmatic attack. **Explanation:** The correct answer is **Acute asthmatic attack**. **1. Mechanism of Action:** Propranolol is a **non-selective beta-blocker**, meaning it antagonizes both $\beta_1$ (cardiac) and $\beta_2$ (bronchial, vascular) receptors. In the lungs, $\beta_2$ receptors are responsible for bronchodilation. By blocking these receptors, propranolol prevents the smooth muscle relaxation mediated by endogenous catecholamines. In patients with reactive airway diseases like COPD or Asthma, this leads to unopposed bronchoconstriction, potentially triggering a life-threatening acute asthmatic attack or severe bronchospasm. **2. Analysis of Incorrect Options:** * **A. Respiratory failure:** While severe bronchospasm can lead to respiratory failure, it is a secondary consequence rather than the immediate, predictive side effect triggered by the drug’s pharmacological action. * **C. Glaucoma:** Propranolol (and other beta-blockers like Timolol) actually *reduces* intraocular pressure by decreasing aqueous humor production; therefore, it is used to treat glaucoma, not a side effect of it. * **D. Pleural effusion:** This is an accumulation of fluid in the pleural space, typically caused by heart failure, infection, or malignancy. It is not a recognized side effect of beta-blocker therapy. **Clinical Pearls for NEET-PG:** * **Cardioselectivity:** In patients with respiratory comorbidities, "cardioselective" $\beta_1$ blockers (e.g., **Metoprolol, Atenolol, Bisoprolol**) are preferred, though they should still be used with extreme caution at low doses. * **Mnemonic for Cardioselective Blockers:** **"New Beta Blockers Act Mainly On Heart"** (Nebivolol, Betaxolol, Bisoprolol, Acebutolol, Metoprolol, Atenolol). * **Absolute Contraindication:** Non-selective beta-blockers are absolutely contraindicated in patients with active bronchial asthma.

Question 1

All of the following are substitutes for atropine except?

Accepted Answer

Drotaverin

Answer

Procyclidine

Answer

Propantheline

Answer

Tiotropium

Question 2

All of the following are peripherally acting muscle relaxants except?

Accepted Answer

Baclofen

Answer

Dantrolene

Answer

Pancuronium

Answer

Succinylcholine

Question 3

Which of the following drugs exhibits an antispasmodic effect?

Accepted Answer

Propantheline

Answer

Neostigmine

Answer

Nikethamide

Answer

Ambenonium

Question 4

Which of the following conditions is a contraindication to vasoconstrictors?

Accepted Answer

All of the above

Answer

Thyrotoxicosis

Answer

Hypertension

Answer

Myocardial Infarction

Question 5

What is the mechanism of action of Oxybutynin?

Accepted Answer

Anticholinergic

Answer

Cholinergic

Answer

Adrenergic

Answer

Selectively inhibits M2 receptor

Question 6

Which of the following is NOT true about d-Tubocurarine (d-TC)?

Accepted Answer

Causes hypotension by ganglion blocking action.

Answer

Excreted unchanged by the kidney.

Answer

Has vagolytic action.

Answer

Effects last for 2-3 hours.

Question 7

Which of the following is NOT a characteristic feature of a non-depolarizing neuromuscular blockade?

Accepted Answer

Potentiated by neostigmine

Answer

Potentiated by magnesium

Answer

Relatively slow onset

Answer

In partial paralysis, nerve stimulation shows fade

Question 8

What is the site of action of vecuronium?

Accepted Answer

Myoneural junction

Answer

Cerebrum

Answer

Reticular formation

Answer

Motor neuron

Question 9

A patient with hypertension also suffers from essential tremor. What is the optimal treatment for this patient?

Accepted Answer

Propranolol

Answer

Clonidine

Answer

Metoprolol

Answer

Lidocaine

Question 10

What is the most predictive and dangerous side effect of propranolol that makes it to be avoided in a known patient of COPD?

Accepted Answer

Acute asthmatic attack

Answer

Respiratory failure

Answer

Glaucoma

Answer

Pleural effusion

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?